These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38386606)

  • 61. South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.
    O'Connor PM; Liyanage JB; Mach O; Anand A; Ramamurty N; Balakrishnan MR; Singh S
    J Infect Dis; 2011 Jul; 204 Suppl 1():S396-402. PubMed ID: 21666190
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased transmission and outbreaks of measles--European Region, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1605-10. PubMed ID: 22129994
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Classification of global measles cases in 2013-17 as due to policy or vaccination failure: a retrospective review of global surveillance data.
    Patel MK; Orenstein WA
    Lancet Glob Health; 2019 Mar; 7(3):e313-e320. PubMed ID: 30784632
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Changing Global Epidemiology of Measles, 2013-2018.
    Patel MK; Antoni S; Nedelec Y; Sodha S; Menning L; Ogbuanu IU; Gacic Dobo M
    J Infect Dis; 2020 Sep; 222(7):1117-1128. PubMed ID: 32135014
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Progress toward regional measles elimination--worldwide, 2000-2013.
    Perry RT; Gacic-Dobo M; Dabbagh A; Mulders MN; Strebel PM; Okwo-Bele JM; Rota PA; Goodson JL;
    MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(45):1034-8. PubMed ID: 25393223
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018.
    Jean Baptiste AE; Masresha B; Wagai J; Luce R; Oteri J; Dieng B; Bawa S; Ikeonu OC; Chukwuji M; Braka F; Sanders EAM; Hahné S; Hak E
    Vaccine; 2021 Nov; 39 Suppl 3():C89-C95. PubMed ID: 33875267
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Progress toward measles elimination--Japan, 1999-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(38):1049-52. PubMed ID: 18818586
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003-2009.
    Zuo S; Cairns L; Hutin Y; Liang X; Tong Y; Zhu Q; Zhang D; Lee LA; Strebel P; Quick L
    Vaccine; 2015 Apr; 33(17):2050-5. PubMed ID: 25769207
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Measles Elimination Activities in the Western Pacific Region: Experience from the Republic of Korea.
    Choe YJ; Jee Y; Oh MD; Lee JK
    J Korean Med Sci; 2015 Nov; 30 Suppl 2(Suppl 2):S115-21. PubMed ID: 26617443
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The African Region early experience with structures for the verification of measles elimination - a review.
    Masresha B; Luce R; Tanifum P; Lebo E; Dosseh A; Mihigo R
    Pan Afr Med J; 2020; 35(Suppl 1):1. PubMed ID: 32373252
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is measles elimination possible in WHO European region up to 2015?
    Paslawska A; Mrozek-Budzyn D
    Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2012-2020.
    Zimmerman LA; Knapp JK; Antoni S; Grant GB; Reef SE
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):196-201. PubMed ID: 35143468
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The unfinished measles immunization agenda.
    Strebel P; Cochi S; Grabowsky M; Bilous J; Hersh BS; Okwo-Bele JM; Hoekstra E; Wright P; Katz S
    J Infect Dis; 2003 May; 187 Suppl 1():S1-7. PubMed ID: 12721885
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Progress toward poliomyelitis eradication in the Eastern Mediterranean Region of the World Health Organization.
    Wahdan MH; Aslanian R; Reichler MR; Gaafar MT
    J Infect Dis; 1997 Feb; 175 Suppl 1():S50-5. PubMed ID: 9203692
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Commitment of measles elimination by 2020: challenges in India.
    Vaidya SR
    Indian Pediatr; 2015 Feb; 52(2):103-6. PubMed ID: 25691174
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regional reports for the subnational monitoring of measles elimination in Italy and the identification of local barriers to the attainment of the elimination goal.
    Adamo G; Sturabotti G; Baccolini V; de Soccio P; Prencipe GP; Bella A; Magurano F; Iannazzo S; Villari P; Marzuillo C
    PLoS One; 2018; 13(10):e0205147. PubMed ID: 30356247
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Progress toward measles elimination in the People's Republic of China, 2000-2009.
    Ma C; An Z; Hao L; Cairns KL; Zhang Y; Ma J; Cao L; Wen N; Xu W; Liang X; Yang W; Luo H
    J Infect Dis; 2011 Jul; 204 Suppl 1():S447-54. PubMed ID: 21666198
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
    Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
    Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluating effective measles vaccine coverage in the Malaysian population accounting for between-dose correlation and vaccine efficacy.
    Kumar SS; Hartner AM; Chandran A; Gaythorpe KAM; Li X
    BMC Public Health; 2023 Nov; 23(1):2351. PubMed ID: 38017415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.